{"id":83805,"date":"2023-12-18T11:12:00","date_gmt":"2023-12-18T14:12:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/"},"modified":"2023-12-18T11:12:00","modified_gmt":"2023-12-18T14:12:00","slug":"biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/","title":{"rendered":"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses"},"content":{"rendered":"<p><b>PR NEWSWIRE<\/b><\/p>\n<div class=\"xn-content\">\n<b><span class=\"xn-person\">Mais de<\/span> 10 mercados emergentes, transi\u00e7\u00e3o no Jap\u00e3o, Austr\u00e1lia e Nova Zel\u00e2ncia em fase final<\/b><\/p>\n<p>SAO POLO, <span class=\"legendSpanClass\">18 de dezembro de 2023<\/span> \/PRNewswire\/ &#8212; <b>A\u00a0Biocon Biologics<\/b>, uma empresa internacional \u00fanica e totalmente integrada de biossimilares, com um rico portf\u00f3lio de insulinas e anticorpos monoclonais, concluiu com sucesso a integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares da Viatris\u00a0com a transi\u00e7\u00e3o de mais de 10 mercados emergentes, al\u00e9m do Jap\u00e3o, Austr\u00e1lia e Nova Zel\u00e2ndia na fase final.<\/p>\n<div id=\"prni_dvprnejpg8a86left\" dir=\"ltr\" style=\"width: 100%;text-align: left\"><img decoding=\"async\" id=\"prnejpg8a86left\" title=\"PFA the banner image\" src=\"https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg\" alt=\"PFA the banner image\" align=\"middle\" data-name=\"url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2302678%2FBiocon_Biologics_PFA.jpg\" \/><\/div>\n<p>Todas\u00a0as marcas de biossimilares da Viatris, incluindo Ogivri&reg; &amp; Hertraz&reg; (bTrastuzumab), Abevmy&reg; (bBevacizumab), Fulphila&reg; (bPegfilgrastim), Hulio&reg; (bAdalimumab), Nepexto&reg; (bEtanercept), Semglee&reg; (bGlargine) e Kirsty&reg; (bAspart ) agora s\u00e3o parte da franquia comercial da Biocon Biologics em mercados avan\u00e7ados e em mais de 80 <a href=\"https:\/\/www.bioconbiologics.com\/biocon-biologics-expands-footprint-in-emerging-markets-takes-over-the-commercialization-of-biosimilars-business-from-viatris-in-70-countries\/\" target=\"_blank\" rel=\"nofollow noopener\">mercados emergentes<\/a>. A maioria destes produtos foi desenvolvida pela Biocon Biologics e est\u00e1 sendo fabricada em suas instala\u00e7\u00f5es de classe mundial na \u00cdndia e Mal\u00e1sia.<\/p>\n<p>A Biocon Biologics ter\u00e1 agora uma forte cobertura comercial em cerca de 120 pa\u00edses, com presen\u00e7a direta nos\u00a0<a href=\"https:\/\/www.bioconbiologics.com\/biocon-biologics-continues-to-expand-global-footprint-completes-integration-of-viatris-biosimilars-business-in-north-america-ahead-of-schedule\/\" target=\"_blank\" rel=\"nofollow noopener\">EUA, Canad\u00e1,<\/a>\u00a0<a href=\"https:\/\/www.bioconbiologics.com\/biocon-biologics-successfully-completes-integration-of-viatris-biosimilar-business-in-31-countries-in-europe\/\" target=\"_blank\" rel=\"nofollow noopener\">Europa<\/a>\u00a0e 9 principais pa\u00edses de mercados emergentes da \u00cdndia, EAU, Ar\u00e1bia Saudita, Marrocos, \u00c1frica do Sul, Brasil, Mal\u00e1sia, Tail\u00e2ndia e Filipinas.<\/p>\n<p><i>&#8220;Estou muito orgulhoso e empolgado por termos conclu\u00eddo com sucesso a integra\u00e7\u00e3o dos neg\u00f3cio adquirido em 120 pa\u00edses. A conclus\u00e3o desta onda final de transi\u00e7\u00e3o \u00e9 um marco significativo e define o come\u00e7o da transforma\u00e7\u00e3o da Biocon Biologics em uma empresa internacional totalmente integrada. Felicito e agrade\u00e7o toda a equipe da Biocon Biologics: colegas, consultores e parceiros. Esta transi\u00e7\u00e3o perfeita, conquistada antes do previsto, \u00e9 o resultado de um foco incessante, esfor\u00e7os incans\u00e1veis e um compromisso inabal\u00e1vel com os pacientes e a continuidade dos neg\u00f3cios.&#8221;\u00a0&#8211;\u00a0<b>Shreehas Tambe, Diretor Executivo e Diretor Geral.<\/b><\/i><\/p>\n<p><i>&#8220;Este marco apresenta uma oportunidade \u00fanica para nossas equipes levarem a Brand Biocon Biologics diretamente a muitos mercados. Este modelo de neg\u00f3cio autodirecionado ir\u00e1 nos aproximar de pacientes, Minist\u00e9rios da Sa\u00fade, prescritores e pagadores. Tamb\u00e9m ir\u00e1 nos possibilitar expandir o acesso a pre\u00e7os acess\u00edveis a grupos maiores de pacientes e gerar economias significativas aos sistemas de sa\u00fade nestes mercados emergentes, permitindo assim acesso equitativo a biossimilares de alta qualidade.&#8221; &#8211;\u00a0<b><span class=\"xn-person\">Susheel Umesh<\/span>, Diretor Comercial de Mercados Emergentes.<\/b><\/i><\/p>\n<p>A Biocon Biologics fez diversas designa\u00e7\u00f5es importantes de lideran\u00e7a, formou novas capacidades e infraestrutura desde o in\u00edcio e criou equipes dedicadas para satisfazer as crescentes necessidades de pacientes e clientes mediante modelos comerciais autodirecionados e dirigidos por parceiros ou distribuidores para garantir a continuidade dos neg\u00f3cios a pacientes, prescritores, parceiros e sistemas de sa\u00fade.<\/p>\n<p>Site:\u00a0<a href=\"https:\/\/www.bioconbiologics.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.bioconbiologics.com<\/a>; Twitter:\u00a0<a href=\"https:\/\/twitter.com\/BioconBiologics?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\" target=\"_blank\" rel=\"nofollow noopener\">@BioconBiologics<\/a>; LinkedIn:\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/bioconbiologics\/\" target=\"_blank\" rel=\"nofollow noopener\">Biocon Biologics<\/a>\u00a0<\/p>\n<p>Foto &#8211;\u00a0<a href=\"https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg<\/a><\/p>\n<p>FONTE  Biocon Biologics Ltd<\/p>\n<\/div>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PT95831&amp;Transmission_Id=202312180900PR_NEWS_LATAM____PT95831&amp;DateId=20231218\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n<p>A <b>OESP<\/b> n\u00e3o \u00e9(s\u00e3o) respons\u00e1vel(is) por erros, incorre\u00e7\u00f5es, atrasos ou quaisquer decis\u00f5es tomadas por seus clientes com base nos Conte\u00fados ora disponibilizados, bem como tais Conte\u00fados n\u00e3o representam a opini\u00e3o da <b>OESP<\/b> e s\u00e3o de inteira responsabilidade da <b>PR Newswire Ltda<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"PR NEWSWIRE Mais de 10 mercados emergentes, transi\u00e7\u00e3o no Jap\u00e3o, Austr\u00e1lia e Nova Zel\u00e2ncia em fase final SAO POLO, 18 de dezembro de 2023 \/PRNewswire\/ &#8212; A\u00a0Biocon Biologics, uma empresa","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[31],"tags":[],"class_list":["post-83805","post","type-post","status-publish","format-standard","hentry","category-prnewsinternacional"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses - Ag\u00eancia de Comunica\u00e7\u00e3o<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses - Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"og:description\" content=\"PR NEWSWIRE Mais de 10 mercados emergentes, transi\u00e7\u00e3o no Jap\u00e3o, Austr\u00e1lia e Nova Zel\u00e2ncia em fase final SAO POLO, 18 de dezembro de 2023 \/PRNewswire\/ &#8212; A\u00a0Biocon Biologics, uma empresa\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/\" \/>\n<meta property=\"og:site_name\" content=\"Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-18T14:12:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg\" \/>\n<meta name=\"author\" content=\"patric_oliveira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"patric_oliveira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/\"},\"author\":{\"name\":\"patric_oliveira\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"headline\":\"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses\",\"datePublished\":\"2023-12-18T14:12:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/\"},\"wordCount\":549,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2302678\\\/Biocon_Biologics_PFA.jpg\",\"articleSection\":[\"PR Newswire Internacional\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/\",\"name\":\"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses - Ag\u00eancia de Comunica\u00e7\u00e3o\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2302678\\\/Biocon_Biologics_PFA.jpg\",\"datePublished\":\"2023-12-18T14:12:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2302678\\\/Biocon_Biologics_PFA.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2302678\\\/Biocon_Biologics_PFA.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewsinternacional\\\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\",\"name\":\"Ag\u00eancia de Comunica\u00e7\u00e3o\",\"description\":\"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\",\"name\":\"patric_oliveira\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"caption\":\"patric_oliveira\"},\"sameAs\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"],\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/author\\\/patric_oliveira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses - Ag\u00eancia de Comunica\u00e7\u00e3o","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/","og_locale":"pt_BR","og_type":"article","og_title":"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses - Ag\u00eancia de Comunica\u00e7\u00e3o","og_description":"PR NEWSWIRE Mais de 10 mercados emergentes, transi\u00e7\u00e3o no Jap\u00e3o, Austr\u00e1lia e Nova Zel\u00e2ncia em fase final SAO POLO, 18 de dezembro de 2023 \/PRNewswire\/ &#8212; A\u00a0Biocon Biologics, uma empresa","og_url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/","og_site_name":"Ag\u00eancia de Comunica\u00e7\u00e3o","article_published_time":"2023-12-18T14:12:00+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg","type":"","width":"","height":""}],"author":"patric_oliveira","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"patric_oliveira","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/#article","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/"},"author":{"name":"patric_oliveira","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"headline":"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses","datePublished":"2023-12-18T14:12:00+00:00","mainEntityOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/"},"wordCount":549,"commentCount":0,"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg","articleSection":["PR Newswire Internacional"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/","name":"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses - Ag\u00eancia de Comunica\u00e7\u00e3o","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/#primaryimage"},"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg","datePublished":"2023-12-18T14:12:00+00:00","author":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"breadcrumb":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2302678\/Biocon_Biologics_PFA.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsinternacional\/biocon-biologics-conclui-integracao-do-negocio-adquirido-de-biossimilares-em-cerca-de-120-paises\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"},{"@type":"ListItem","position":2,"name":"Biocon Biologics conclui integra\u00e7\u00e3o do neg\u00f3cio adquirido de biossimilares em cerca de 120 pa\u00edses"}]},{"@type":"WebSite","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/","name":"Ag\u00eancia de Comunica\u00e7\u00e3o","description":"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37","name":"patric_oliveira","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","caption":"patric_oliveira"},"sameAs":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"],"url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/author\/patric_oliveira\/"}]}},"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/83805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=83805"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/83805\/revisions"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=83805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=83805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=83805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}